Document is current
Any future updates will be listed below
-
Authors
Faraldo, Marisa M.
Romagnoli, Mathilde
Wallon, Loane
Dubus, Pierre
Deugnier, Marie-Ange
Fre, Silvia
-
Funding
Funding for this research was provided by:
Ligue Nationale Contre le Cancer (RS16/75-70)
Labex CelTisPhybio (ANR-10-LABX-0038)
Fondation pour la Recherche Médicale (EQU201903007821)
Fondation Schlumberger pour l'éducation et la recherche (FSER20200211117)
ARC - Research association against cancer (ARCPGA2021120004232_4874)
Labex DEEP ANR (11-LBX-0044)
- License Information
-
More Information
Article History
Received: 19 December 2023
Accepted: 28 May 2024
First Online: 4 June 2024
Declarations
:
: All studies and procedures involving animals were in accordance with the recommendations of the European Community (2010/63/UE) for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes. Approval was provided by the ethics committee of the French Ministry of Research (reference APAFIS #37016-2022042813038138v1). We comply with internationally established principles of replacement, reduction, and refinement in accordance with the Guide for the Care and Use of Laboratory Animals (NRC 2011).
: Not applicable.
: The authors declare that they have no competing interest.
